Enyo Pharma

Developer of therapeutics for diseases with impaired kidney function

placeLyon, Auvergne Rhone Alpes, France calendar_todayFounded 2014 groups34 employees language enyopharma.com

Social engagement

Social engagement: 8.9K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Sofinnova Partners, Morningside, Orbimed.

Investor typeCountShare
Venture capital655%
Private equity19%
Accelerator & incubator19%
Bank & private debt19%
Other / undisclosed218%

Recent activity

19 Jun 2026
Event
BIO International Convention 2026
3 Jun 2026
Leadership hire
Chairman
4 May 2026
Event
Bio€quity Europe
Coming soon